Author: GarcÃa-Montoya, Isui Abril; Cendón, Tania Siqueiros; Arévalo-Gallegos, Sigifredo; Rascón-Cruz, QuintÃn
Title: Lactoferrin a multiple bioactive protein: An overview() Cord-id: mzak7czg Document date: 2011_6_25
ID: mzak7czg
Snippet: BACKGROUND: Lactoferrin (Lf) is an 80 kDa iron-binding glycoprotein of the transferrin family. It is abundant in milk and in most biological fluids and is a cell-secreted molecule that bridges innate and adaptive immune function in mammals. Its protective effects range from anticancer, anti-inflammatory and immune modulator activities to antimicrobial activities against a large number of microorganisms. This wide range of activities is made possible by mechanisms of action involving not only the
Document: BACKGROUND: Lactoferrin (Lf) is an 80 kDa iron-binding glycoprotein of the transferrin family. It is abundant in milk and in most biological fluids and is a cell-secreted molecule that bridges innate and adaptive immune function in mammals. Its protective effects range from anticancer, anti-inflammatory and immune modulator activities to antimicrobial activities against a large number of microorganisms. This wide range of activities is made possible by mechanisms of action involving not only the capacity of Lf to bind iron but also interactions of Lf with molecular and cellular components of both hosts and pathogens. SCOPE OF REVIEW: This review summarizes the activities of Lf, its regulation and potential applications. MAJOR CONCLUSIONS: The extensive uses of Lf in the treatment of various infectious diseases in animals and humans has been the driving force in Lf research however, a lot of work is required to obtain a better understanding of its activity. GENERAL SIGNIFICANCE: The large potential applications of Lf have led scientists to develop this nutraceutical protein for use in feed, food and pharmaceutical applications. This article is part of a Special Issue entitled Molecular Mechanisms of Iron Transport and Disorders.
Search related documents:
Co phrase search for related documents- active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory and adaptative immune response: 1
- acute respiratory and additional functionality: 1, 2
- acute respiratory and adhesion method: 1
- acute respiratory and low infection level: 1, 2, 3, 4
- acute respiratory and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- acute respiratory and lymph node dendritic cell: 1, 2
- acute respiratory and lymph node dendritic cell accumulation: 1
- acute respiratory syndrome and adaptative immune response: 1
- acute respiratory syndrome and additional functionality: 1, 2
- acute respiratory syndrome and adhesion method: 1
- acute respiratory syndrome and low infection level: 1, 2, 3
- acute respiratory syndrome and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- acute respiratory syndrome and lymph node dendritic cell: 1, 2
- acute respiratory syndrome and lymph node dendritic cell accumulation: 1
- low infection level and lymph node: 1
Co phrase search for related documents, hyperlinks ordered by date